Search Results for: EGFR

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
SNX9 sorting nexin 9
  • Golgi Associated Vesicle Biogenesis
  • Clathrin-mediated endocytosis
SOCS5 suppressor of cytokine signaling 5
  • Interleukin-4 and Interleukin-13 signaling
  • Neddylation
SPARCL1 SPARC like 1
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Post-translational protein phosphorylation
TPI1 triosephosphate isomerase 1
  • Glycolysis
  • Gluconeogenesis
  • Zinc
  • N-Hydroxy-4-Phosphono-Butanamide
  • 2-Phosphoglycolic Acid
  • Phosphoglycolohydroxamic Acid
  • 3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid
  • [2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid
  • 5-fluorotryptophan
  • 2-Carboxyethylphosphonic Acid
  • tert-butanol
  • Dihydroxyacetone phosphate
  • 1,4-Dithiothreitol
  • 3-phospho-D-glyceric acid
  • 3-(BUTYLSULPHONYL)-PROPANOIC ACID
  • Artenimol
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
  • Anemia due to disorders of glycolytic enzymes, including: Hexokinase (HK) deficiency; Phosphoglycerate kinase 1 (PGK1) deficiency; Triose-phosphate isomerase (TPI) deficiency; Glucose phosphate isomerase (GPI) deficiency; Bisphosphoglycerate mutase (BPGM) deficiency
TPM1 tropomyosin 1
  • Striated Muscle Contraction
  • Smooth Muscle Contraction
  • Artenimol
  • Phenethyl Isothiocyanate
  • Hypertrophic cardiomyopathy (HCM)
  • Dilated cardiomyopathy (DCM)
TXK TXK tyrosine kinase
  • FCERI mediated Ca+2 mobilization
  • FCERI mediated Ca+2 mobilization
  • Fostamatinib
  • Zanubrutinib
ZAP70 zeta chain of T cell receptor associated protein kinase 70
  • Translocation of ZAP-70 to Immunological synapse
  • Generation of second messenger molecules
  • Staurosporine
  • Fostamatinib
  • Combined immunodeficiencies (CIDs), including the following nine diseases: X-linked hyper IgM syndrome; CD40 deficiency hyper IgM syndrome; Purine nucleoside phosphorylase (PNP) deficiency; Omenn syndrome; MHC deficiency (HLA-class I); MHC deficiency (HLA-class II); Zap-70 deficiency; p56 Lck deficiency; CD8 deficiency
ACTA1 actin alpha 1, skeletal muscle
  • Striated Muscle Contraction
  • Latrunculin A
  • Sucrose
  • Ulapualide A
  • Kabiramide C
  • Jaspisamide A
  • Tmr
  • 1-Methylhistidine
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • Aplyronine A
  • Reidispongiolide A
  • Reidispongiolide C
  • Sphinxolide B
  • Latrunculin B
  • Congenital fiber type disproportion (CFTD)
  • Cap myopathy
  • Nemaline myopathy
ALCAM activated leukocyte cell adhesion molecule
  • L1CAM interactions
AOPEP aminopeptidase O (putative)
  • Metabolism of Angiotensinogen to Angiotensins
APBA3 amyloid beta precursor protein binding family A member 3
  • Neurexins and neuroligins
APBB1 amyloid beta precursor protein binding family B member 1
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
APPL1 adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1
  • Caspase activation via Dependence Receptors in the absence of ligand
ATIC 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
  • Purine ribonucleoside monophosphate biosynthesis
  • Tetrahydrofolic acid
  • Methotrexate
  • Pemetrexed
  • AICA ribonucleotide
  • Guanosine-5'-Monophosphate
  • 5-monophosphate-9-beta-D-ribofuranosyl xanthine
  • Acid yellow 54 free acid
  • N-[4-([(2-Amino-4-oxo-1,4-dihydropyrido[3,2-d]pyrimidin-6-yl)methyl]{(2E)-3-[4-carbamoyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazol-5-yl]-2-propenoyl}amino)benzoyl]-L-glutamic acid
  • AICA-ribosiduria; ATIC deficiency
AXL AXL receptor tyrosine kinase
  • VEGFA-VEGFR2 Pathway
  • Fostamatinib
  • Gilteritinib
CAMLG calcium modulating ligand
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Cyclosporine
CAV2 caveolin 2
  • Extra-nuclear estrogen signaling
CBLB Cbl proto-oncogene B
  • Antigen processing: Ubiquitination & Proteasome degradation
CSRP1 cysteine and glycine rich protein 1
  • MTF1 activates gene expression
  • Artenimol
DOK4 docking protein 4
  • RET signaling

Page 14 out of 21 pages